Department of Pediatrics, Baylor College of Medicine, Houston, TX (M.A., S.C.).
Department of Pediatrics, Washington University School of Medicine, St Louis, MO (R.M.G., S.A., G.K.S.).
Circ Cardiovasc Imaging. 2018 Dec;11(12):e007964. doi: 10.1161/CIRCIMAGING.118.007964.
Pulmonary arterial hypertension is a progressive disease with poor outcomes in children. Right ventricular (RV) function is the most important determinant of the prognosis. Novel application of Potts shunt between left pulmonary artery and descending aorta has been introduced in an attempt to improve the survival. However, the effect of Potts shunt creation on RV function, RV-PA coupling, and survival has not been studied.
We evaluated the first 12 consecutive pediatric patients (9 male, median age 11.2 years and weight 32.8 kg) who underwent elective Potts shunt placement for suprasystemic pulmonary arterial hypertension between 2013 and 2017 with echocardiographic indices of RV function, RV work, RV-PA coupling, and pulmonary hemodynamics. Of 12 patients, 1 was excluded because of insufficient preshunt data, 2 died, 1 required lung transplant, and 8 survived for a median of 27 months postshunt. In survivors, WHO functional class significantly ( P=0.01) improved and the majority (5 of 8) came off pulmonary vasodilators at the most recent follow-up. Postshunt RV systolic function improved ( P=0.03), RV afterload decreased ( P <0.01), RV work decreased ( P=0.02), and RV-proximal PA coupling improved ( P<0.01).
This proof of concept study shows that Potts shunt allows improvement in functional status and mid-term transplant-free survival in the majority of the recipients by improvement in RV systolic function and RV-PA coupling in children with suprasystemic pulmonary arterial hypertension.
肺动脉高压是一种进行性疾病,患儿预后不良。右心室(RV)功能是预后的最重要决定因素。已经引入了左肺动脉与降主动脉之间的新型 Potts 分流术,试图改善生存。然而,Potts 分流术对 RV 功能、RV-PA 偶联和生存的影响尚未研究。
我们评估了 2013 年至 2017 年间连续 12 例接受择期 Potts 分流术治疗超系统肺动脉高压的儿科患者(9 名男性,中位年龄 11.2 岁,体重 32.8kg)的超声心动图 RV 功能、RV 做功、RV-PA 偶联和肺血流动力学的指标。在 12 例患者中,1 例因术前数据不足而被排除,2 例死亡,1 例需要肺移植,8 例患者存活时间中位数为分流术后 27 个月。在存活者中,WHO 功能分级显著改善(P=0.01),大多数(8 例中的 5 例)在最近的随访中停止了肺动脉扩张剂治疗。分流术后 RV 收缩功能改善(P=0.03),RV 后负荷降低(P<0.01),RV 做功降低(P=0.02),RV 近端 PA 偶联改善(P<0.01)。
这项概念验证研究表明,Potts 分流术可通过改善超系统肺动脉高压患儿 RV 收缩功能和 RV-PA 偶联,改善大多数患者的功能状态和中期无移植生存率。